Skip to main content

Table 3 Participant characteristics per cluster

From: Symptom-based clusters in people with ME/CFS: an illustration of clinical variety in a cross-sectional cohort

 

Cluster 2 (n = 24)

Cluster 4 (n = 23)

Cluster 7 (n = 30)

Cluster 9 (n = 26)

Cluster 11 (n = 17)

Cluster 19 (n = 19)

Cluster 24 (n = 43)

Cluster 26 (n = 18)

Cluster 28 (n = 38)

Cluster 31 (n = 15)

Cluster 36 (n = 10)

Cluster 37 (n = 18)

Cluster 40 (n = 20)

Sex, n (%)

 Male

6 (25.0)

2 (8.7)

8 (26.7)

4 (15.4)

6 (35.3)

8 (42.1)

4 (9.3)

3 (16.7)

2 (5.3)1

3 (20.0)

1 (10.0)

6 (33.3)

2 (10.0)

 Female

18 (75.0)

21 (91.3)

22 (73.3)

22 (84.6)

11 (64.7)

10 (52.6)

39 (90.7)

15 (83.3)

36 (94.7)

12 (80.0)

9 (90.0)

12 (66.7)

17 (85.0)

 Other/I don’t want to say

1 (5.3)

1 (5.0)

Age, years

52 (47–61)

38 (27–48)2

55 (45–58)

55 (39–60)

51 (39–62)

60 (50–70)

59 (51–64)

52 (44–61)

57 (39–63)

52 (43–59)

52 (41–58)

61 (53–71)

62 (52–70)

BMI, kg/m2

24.6 (21.4–29.0)

20.9 (20.3–27.6)

26.0 (21.7–30.7)

23.4 (21.9–26.5)

24.0 (19.6–26.2)

25.9 (21.5–31.2)

24.5 (22.3–28.6)

23.5 (21.2–26.1)

24.2 (21.4–29.6)

21.3 (20.3–25.3)

22.7 (21.0–27.9)

25.4 (22.8–26.8)

22.4 (19.8–28.1)

Ethnicity, n (%)

 Black, African-American

1 (4.2)

 White

22 (91.7)

23 (100.0)

29 (96.7)

24 (92.3)

17 (100.0)

18 (94.7)

43 (100.0)

17 (94.4)

37 (97.4)

15 (100.0)

9 (90.0)

18 (100.0)

19 (95.0)

 American Indian/Alaska Native

 Asian or Pacific Islander

1 (4.2)

1 (10.0)

 Other

1 (3.3)

2 (7.7)

1 (5.3)

1 (5.6)

1 (2.6)

1 (5.0)

Marital status, n (%)

 Married or living with partner

15 (62.5)

9 (39.1)

16 (53.3)

13 (50.0)

8 (47.1)

8 (42.1)

27 (62.8)

13 (72.2)

22 (57.9)

12 (80.0)

2 (20.0)

8 (44.4)

13 (65.0)

 Living alone

8 (33.3)

12 (52.2)

10 (33.3)

11 (42.3)

8 (47.1)

7 (36.8)

14 (32.6)

5 (27.8)

15 (39.5)

3 (20.0)

6 (60.0)

8 (44.4)

6 (30.0)

 Widow(er)/divorced

1 (4.2)

2 (8.7)

4 (13.3)

2 (7.7)

1 (5.9)

4 (21.1)

2 (4.7)

1 (2.6)

2 (20.0)

2 (11.1)

1 (5.0)

Children, n (%)

 No

12 (50.0)

16 (69.6)

16 (53.3)

15 (57.7)

9 (52.9)

9 (47.4)

24 (55.8)

9 (50.0)

22 (57.9)

8 (53.3)

4 (40.0)

7 (38.9)

9 (45.0)

 Yes

12 (50.0)

7 (30.4)

14 (46.7)

11 (42.3)

8 (47.1)

10 (52.6)

19 (44.2)

9 (50.0)

16 (42.1)

7 (46.7)

6 (60.0)

11 (61.1)

11 (55.0)

Education level, n (%)a

 Low

1 (4.2)

2 (10.5)

1 (2.3)

3 (16.7)

1 (2.6)

1 (10.0)

1 (5.6)

 Medium

7 (29.2)

8 (34.8)

13 (43.3)

9 (34.6)

6 (35.3)

10 (52.6)

19 (44.2)

6 (33.3)

10 (26.3)

7 (46.7)

5 (50.0)

1 (5.6)

7 (35.0)

 High

16 (66.7)

14 (60.9)

17 (56.7)

16 (61.5)

11 (64.7)

7 (36.8)

23 (53.5)

9 (50.0)

27 (71.1)

8 (53.3)

4 (40.0)

15 (83.3)

13 (65.0)

 Other/I don’t want to say

1 (4.3)

1 (3.8)

1 (5.6)

Current work status, n (%)b

 On disability

16 (66.7)

19 (82.6)

25 (83.3)

18 (69.2)

12 (70.6)

7 (36.8)

31 (72.1)

14 (77.8)

18 (47.4)

8 (53.3)

10 (100.0)

4 (22.2)3

10 (50.0)

 Student

2 (8.7)

1 (5.6)

1 (6.7)

1 (5.6)

 Homemaker

3 (12.5)

1 (4.3)

1 (3.3)

1 (3.8)

2 (11.8)

1 (5.3)

9 (20.9)

1 (5.6)

1 (2.6)

2 (13.3)

3 (15.0)

 Retired

1 (4.2)

1 (3.3)

3 (11.5)

2 (11.8)

8 (42.1)4

7 (16.3)

2 (11.1)

6 (15.8)

3 (20.0)

1 (10.0)

8 (44.4)4

7 (35.0)

 Unemployed

3 (12.5)

1 (4.3)

2 (11.8)

1 (5.3)

3 (7.0)

1 (5.6)

4 (10.5)

1 (6.7)

1 (5.6)

2 (10)

 Working part-time

10 (41.7)5

2 (8.7)

5

4 (15.4)

3 (17.6)

2 (10.5)

5 (11.6)

1 (5.6)

11 (28.9)

2 (13.3)

1 (10.0)

5 (27.8)

6 (30.0)

 Working full-time

1 (4.2)

3 (10.0)

2 (10.5)

2 (5.3)

1 (5.6)

-

Case definition, n (%)

 Fukuda Criteria

20 (83.3)

21 (91.3)

26 (86.7)

26 (100.0)

17 (100.0)

16 (84.2)

39 (90.7)

15 (83.3)

34 (89.5)

14 (93.3)

5 (50.0)6

17 (94.4)

20 (100.0)

 Canadian Clinical ME/CFS Criteria

12 (50.0)

15 (65.2)

26 (86.7)

26 (100.0)

9 (52.9)

3 (15.8)7

35 (81.4)

13 (72.2)

6 (15.8)7

11 (73.3)

5 (50.0)

7

9 (45.0)

 International Consensus Criteria

3 (12.5)

6 (26.1)

14 (46.7)

21 (80.8)8

6 (35.3)

3 (15.8)

19 (44.2)

18 (100.0)9

1 (2.6)

6 (40.0)

10 (100.0)8

8 (40.0)

 Institute of Medicine

19 (79.2)

21 (91.3)

26 (86.7)

26 (100.0)

17 (100.0)

12 (63.2)

39 (90.7)

15 (83.3)

26 (68.4)

14 (93.3)

5 (50.0)

4 (22.2)10

16 (80.0)

Nr. of case definition, n (%)

 0

3 (12.5)

2 (8.7)

2 (6.7)

2 (10.5)

1 (2.3)

3 (7.9)

1 (5.6)

 1

1 (4.2)

2 (6.7)

5 (26.3)

3 (7.0)

3 (16.7)

9 (23.7)

1 (6.7)

5 (50.0)

13 (72.2)11

2 (10.0)

 2

9 (37.5)

2 (8.7)

6 (35.3)

7 (36.8)

4 (9.3)

20 (52.6)12

2 (13.3)

4 (22.2)

7 (35.0)

 3

9 (37.5)

11 (47.8)

14 (46.7)

5 (19.2)

7 (41.2)

5 (26.3)

19 (44.2)

2 (11.1)

6 (15.8)

8 (53.3)

13

7 (35.0)

 4

2 (8.3)

5 (21.7)

12 (40.0)

21 (80.8)14

4 (23.5)

16 (37.2)

13 (72.2)10

4 (26.7)

5 (50.0)

4 (20.0)

Number or reported symptoms, median (IQR)c

22 (19–27)15

28 (23–31)16

38 (34–43)

41 (36–44)

23 (21–26)15

17 (14–22)15

31 (27–34)16

45 (41–53)

15 (11–19)17

28 (25–32)16

61 (59–62)

8 (4–11)18

21 (17–26)15

  1. 1p < 0.05 versus clusters 19; 2p < 0.05 versus clusters 7, 19, 24, 28, 37 and 40; 3p < 0.05 versus clusters 4, 7, 24, 26, and 36; 4p < 0.05 versus clusters 2, 4, and 7; 5p < 0.05 versus all other clusters; 6p < 0.05 versus clusters 4, 7, 9, 11, 24, 28, 31, 37, and 40; 7p < 0.05 versus clusters 4, 7, 9, 24, 26, and 31; 8p < 0.05 versus clusters 2, 4, 19, 28, and 37; 9p < 0.05 versus clusters 2, 4, 7, 11, 19, 24, 28, 31, 37, and 40; 10p < 0.05 versus clusters 2, 4, 7, 9, 11, 24, 26, 28, 31, and 40; 11p < 0.05 versus clusters 2, 4, 7, 9, 11, 19, 24, 26, 28, 31, and 40; 12p < 0.05 versus clusters 7, 9, 24, 26, and 36; 13p < 0.05 versus clusters 7 and 24; 14p < 0.05 versus clusters 2, 4, 19, 28, 37, and 40; 15p < 0.05 versus clusters 7, 9, 24, 26 and 36; 16p < 0.05 versus clusters 26 and 36; 17p < 0.05 versus clusters 4, 7, 9, 24, 26, 31 and 36; 18p < 0.05 versus clusters 2, 4, 7, 9, 11, 24, 26, 31, 36 and 40
  2. aClassification according to the International Standard Classification of Education 2011[35]
  3. bMultiple answers possible
  4. cUsing the 2/2 threshold for severity and frequency